Mediar Therapeutics
- Bryan Fuchs
BF
Bryan Fuchs
Scientific Advisor at Mediar Therapeutics
My lab studies the biological mechanisms that cause liver fibrosis and liver cancer. We have a particular interest in developing novel models and imaging techniques to study these diseases in order to evaluate new therapies and identify effective biomarkers.
Timeline
Scientific Advisor
Current role
Related people
Marek Rei
Scientific Advisor And Co-founder at Transformative
Samuel P. Wertheimer
Managing Partner & Senior Scientific Advisor at Brookline Capital Markets
Katerina Akassoglou
Chair of the Scientific Advisory Board at Therini Bio, Inc.
Mina Bissell
Scientific Advisor at zPREDICTA
Douglas Hofmann
Co-Founder and Scientific Advisor at Amorphology, Inc
BUSINESS
EVERY ORG CHART
Access the worlds's biggest network of public org charts
Learn more